Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Onychomycosis (Tinea Unguium) - Overview
Onychomycosis (Tinea Unguium) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Onychomycosis (Tinea Unguium) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Onychomycosis (Tinea Unguium) - Companies Involved in Therapeutics Development
Acea Biotech Inc
Almirall SA
ASCIL Biopharm
Blueberry Therapeutics Ltd
CSA Biotechnologies LLC
DermBiont Inc
Exodos Life Sciences Limited Partnership
Hallux Inc
Hexima Ltd
Kaken Pharmaceutical Co Ltd
Moberg Pharma AB
Mycovia Pharmaceuticals Inc
L Pharmaceuticals Ltd
Novabiotics Ltd
Photomic GmbH & Co KG
SaNOtize Research and Development Corp
Onychomycosis (Tinea Unguium) - Drug Profiles
aminolevulinic acid hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Amphotericin B sodium - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BB-0305 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DBI-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ELS-160 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HXP-124 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KP-607 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
L-3210 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NORS-0791 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NP-213 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
onymed - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
otesecozole - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
P-3058 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Disrupt Cell Membrane for Onychomycosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
terbifine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
terbifine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
terbifine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Onychomycosis (Tinea Unguium) - Dormant Projects
Onychomycosis (Tinea Unguium) - Discontinued Products
Onychomycosis (Tinea Unguium) - Product Development Milestones
Featured News & Press Releases
Jan 07, 2021: Updated timeline to phase IIb results
Oct 14, 2020: Moberg Pharma intends to submit a registration application in Europe in 2021
Jun 25, 2020: Moberg Pharma meets primary endpoint in the European phase 3 study
Mar 23, 2020: All patients in the European MOB-015 Phase 3 study have completed their last visit
Jan 28, 2020: Blueberry Therapeutics receives clearance from the FDA to proceed with the clinical investigation of BB2603
Jan 22, 2020: Expert evaluation clarifies phase 3 results and provides strong support for MOB-015
Dec 12, 2019: Moberg Pharma comments on the results of the North American Phase 3 study with MOB-015
Dec 09, 2019: Moberg Pharma meets primary endpoint for MOB-015 in a phase 3 study for the treatment of Onychomycosis
Apr 18, 2019: UK-Based nomedicine firm set plans to initiate a large phase II efficacy study in 2019
Mar 22, 2019: Moberg Pharma completes enrollment for MOB-015 phase 3 study in Europe
Dec 18, 2018: Almirall announces that the Phase III trial of P-3058 for onychomycosis achieved primary endpoint
Nov 23, 2018: Blueberry reports positive results from Phase I/II BB2603 trial
Nov 23, 2018: Moberg Pharma: Patent granted for MOB-015 in Chi
Sep 11, 2018: Moberg Pharma has completed enrollment to Phase 3 study for MOB-015 in North America
Nov 21, 2017: Hexima Receives Approval to Conduct a Phase 1/2a Study for Fungal il Infections
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Onychomycosis (Tinea Unguium), 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021


List of Tables


Number of Products under Development for Onychomycosis (Tinea Unguium), 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Acea Biotech Inc, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Almirall SA, 2021
Onychomycosis (Tinea Unguium) - Pipeline by ASCIL Biopharm, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Blueberry Therapeutics Ltd, 2021
Onychomycosis (Tinea Unguium) - Pipeline by CSA Biotechnologies LLC, 2021
Onychomycosis (Tinea Unguium) - Pipeline by DermBiont Inc, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Exodos Life Sciences Limited Partnership, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Hallux Inc, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Hexima Ltd, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Kaken Pharmaceutical Co Ltd, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Moberg Pharma AB, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Mycovia Pharmaceuticals Inc, 2021
Onychomycosis (Tinea Unguium) - Pipeline by NAL Pharmaceuticals Ltd, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Novabiotics Ltd, 2021
Onychomycosis (Tinea Unguium) - Pipeline by Photonamic GmbH & Co KG, 2021
Onychomycosis (Tinea Unguium) - Pipeline by SaNOtize Research and Development Corp, 2021
Onychomycosis (Tinea Unguium) - Dormant Projects, 2021
Onychomycosis (Tinea Unguium) - Dormant Projects, 2021 (Contd..1)
Onychomycosis (Tinea Unguium) - Dormant Projects, 2021 (Contd..2)
Onychomycosis (Tinea Unguium) - Discontinued Products, 2021